ITALIAN JOURNAL OF PUBLIC HEALTH Epidemiologia e ... - Ijph.it

IJPH - Year 8, Volume 7, Number 2, Suppl. 2, 2010
I T A L I A N J O U R N A L O F P U B L I C H E A L T H
51) Silman AJ, Ollier W, Holligan S, et al. Absence of
rheumatoid arthritis in a rural Nigerian population. J Rheumatol
1993;20:618–22.
52) del Puente A, Knowler WC, Pettit DJ, Bennett PH. High
incidence and prevalence of rheumatoid arthritis in Pima
Indians. Am J Epidemiol 1989;129:1170-8.
53) Crowson CS, O’Fallon WM. The epidemiology of
rheumatoid arthritis in Rochester, Minnesota, 1955–1985.
Arthritis Rheum 1999;42:415–20.
54) Symmons DP, Barrett EM, Bankhead CR, Scott DG,
Silman AJ. The incidence of rheumatoid arthritis in the
United Kingdom: results of the Norfolk Arthritis Register. Br J
Rheumatol 1994;33:735-9.
55) Doran MF, Pond GR, Crowson CS, O’Fallon WM, Gabriel
SE. Trends in incidence and mortality in rheumatoid arthritis
in Rochester, Minnesota, over a forty-year period. Arthritis
Rheum 2002;46:625–31.
56) Soderlin MK, Borjesson O, Kautiainen H, Skogh T,
Leirisalo-Repo M. Annual incidence of inflammatory joint
diseases in a population study in southern Sweden. Ann
Rheum Dis 2002;61:911-5.
57) Shichikawa K, Inoue K, Hirota S, et al. Changes in
the incidence and prevalence of rheumatoid arthritis in
Kamitonda, Wakayama, Japan,1965–1996. Ann Rheum Dis
1999;58:751–6.
58) Guillemin F, Briancon S, Klein JM, Sauleau E, Pourel J. Low
incidence of rheumatoid arthritis in France. Scand J Rheumatol
1994;23:264-8.
59) Pedersen JK, Kjær NK, Svendsen AJ, Hørslev-Petersen K.
Incidence of rheumatoid arthritis from 1995 to 2001: impact
of ascertainment from multiple sources. Rheumatol Int 2009;
29:411–5.
60) Pedersen KJ, Svendsen AJ, Hørslev-Petersen K. Incidence
of Rheumatoid Arthritis in the Southern part of Denmark from
1995 to 2001. Open Rheumatol J 2007;1:18-23.
61) Kaipiainen-Seppanen O, Aho K. Incidence of chronic
inflammatory joint diseases in Finland in 1995. J Rheumatol
2000;27:94-100.
62) Rodríguez LA, Tolosa LB, Ruigómez A, Johansson S,
Wallander MA. Rheumatoid arthritis in UK primary
care: incidence and prior morbidity. Scand J Rheumatol
2009;38:173–7.
63) Wiles N, Symmons DP, Harrison B, et al. Estimating the
incidence of rheumatoid arthritis: trying to hit a moving
target? Arthritis Rheum 1999;42:1339-46.
64) Oen KG, Cheang M. Epidemiology of chronic arthritis in
childhood. Semin Arthritis Rheum 1996;26:575-91.
65) von Koskull S, Truckenbrodt H, Holle R, Hormann A.
Incidence and prevalence of juvenile arthritis in an urban
population of southern Germany: a prospective study. Ann
Rheum Dis 2001;60:940-5.
66) Kaipiainen-Seppanen O, Savolainen A. Changes in
the incidence of juvenile rheumatoid arthritis in Finland.
Rheumatology 2001;40:928-32.
67) Gabriel SE, Michaud K. Epidemiological studies in
incidence, prevalence, mortality, and comorbidity of the
rheumatic diseases. Arthritis Res Ther 2009;11:229.
68) Jacobsson LTH, Hanson RL, Knowler WC, et al. Decreasing
incidence and prevalence of rheumatoid arthritis in Pima
Indians over a twenty-five-year period. Arthritis Rheum 1994;
37:1158-65.
69) Gabriel SE, Crowson CS, O’Fallon WM. Mortality in
rheumatoid arthritis: have we made an impact in 4 decades? J
Rheumatol 1999;26:2529-33.
70) Kvalvik AG, Jones MA, Symmons DP. Mortality in a cohort
of Norwegian patients with rheumatoid arthritis followed
from 1977 to 1992. Scand J Rheumatol 2000;29:29-37.
71) Krause D, Schleusser B, Herborn G, Rau R. Response to
methotrexate treatment is associated with reduced mortality
in patients with severe rheumatoid arthritis. Arthritis Rheum
2000; 43:14-21.
72) Young A, Koduri G, Batley M, et al. Mortality in rheumatoid
arthritis. Increased in the early course of disease, in ischaemic
heart disease and in pulmonary fibrosis. Rheumatology
(Oxford) 2007;46:350-7.
73) Prior P, Symmons DP, Scott DL, Brown R, Hawkins
CF. Cause of death in rheumatoid arthritis. Br J Rheumatol
1984;23:92–9.
74) Symmons DP, Jones MA, Scott DL, Prior P. Longterm
mortality outcome in patients with rheumatoid arthritis: early
presenters continue to do well. J Rheumatol 1998;25:1072–7.
75) Allebeck P. Increased mortality in rheumatoid arthritis.
Scand J Rheumatol 1982;11:81–6.
76) Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA,
Williams CA, et al. The mortality of rheumatoid arthritis.
Arthritis Rheum 1994;37:481–94.
77) Monson RR, Hall AP. Mortality among arthritics. J Chronic
Dis 1976;29:459–67.
78) Mutru O, Laakso M, Isomaki H, Koota K. Ten year mortality
and causes of death in patients with rheumatoid arthritis. Br
Med J (Clin Res Ed) 1985;290:1797–9.
79) Wallberg-Jonsson S, Ohman ML, Dahlqvist SR.
Cardiovascular morbidity and mortality in patients with
seropositive rheumatoid arthritis in Northern Sweden. J
Rheumatol 1997;24:445–51.
80) Mitchell DM, Spitz PW, Young DY, Bloch DA, McShane
DJ, Fries JF. Survival, prognosis, and causes of death in
rheumatoid arthritis. Arthritis Rheum 1986;29:706–14.
81) Kvalvik AG, Jones MA, Symmons DP. Mortality in a cohort
of Norwegian patients with rheumatoid arthritis followed
from 1977 to 1992. Scand J Rheumatol 2000;29:29–37.
82) Reilly PA, Cosh JA, Maddison PJ, Rasker JJ, Silman
AJ. Mortality and survival in rheumatoid arthritis: a 25
year prospective study of 100 patients. Ann Rheum Dis
1990;49:363–9.
83) Myllykangas-Luosujarvi RA, Aho K, Isomaki HA. Mortality
in rheumatoid arthritis. Semin Arthritis Rheum 1995;25:193–
202.
84.) Cobb S, Anderson F, Bauer W. Length of life and cause of
death in rheumatoid arthritis. N Engl J Med 1953;249:553–6.
85) Allebeck P, Ahlbom A, Allander E. Increased mortality
among persons with rheumatoid arthritis, but where RA does
not appear on death certificate: eleven-year follow-up of an
epidemiological study. Scand J Rheumatol 1981;10:301–6.
86) Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE,
Vaughn WK. Severe functional declines, work disability, and
increased mortality in seventy-five rheumatoid arthritis patients
studied over nine years. Arthritis Rheum 1984;27:864–72.
87) Uddin J, Kraus AS, Kelly HG. Survivorship and death in
rheumatoid arthritis. Arthritis Rheum 1970;13:125–30.
88) Jacobsson LTH, Knowler WC, Pillemer S, et al. Rheumatoid
arthritis and mortality: a longitudinal study in Pima Indians.
Arthritis Rheum 1993;36:1045–53.
89) Lewis P, Hazleman BL, Hanka R, Roberts S. Cause of death
in patients with rheumatoid arthritis with particular reference
to azathioprine. Ann Rheum Dis 1980;39:457–61.
90) Linos A, Worthington JW, O’Fallon WM, Kurland LT.
The epidemiology of rheumatoid arthritis in Rochester,
Minnesota: a study of incidence, prevalence, and mortality.
Am J Epidemiol 1980;111:87–98.
91) Ward MM. Recent improvements in survival in patients
with rheumatoid arthritis: better outcomes or different study
designs? Arthritis Rheum 2001;44:1467–9.
92) Neri Serneri GG, Bartoli V. Sulla eredopatologia delle
mesenchimopatie reattive (cosidette malattie del collageno).
II. Ricerche sui fattori ereditari del reumatismo cronico
primario. Acta Genet Med Gemellol 1956;5:402–25.
93) Einaudi G. Indagini sulla diffusione e sulle caratteristiche
delle malattie di interesse cardio-reumatologico nella
popolazione totale di un paese della provincia di Torino.
S 1 2 C a p i t o l o 2